Teijin Limited and Versartis Enter Strategic Alliance for Commercialization of Somavaratan Long-Acting Growth Hormone in Japan Teijin’s regulatory and commercial infrastructure ideally suited to capitalize on somavaratan, which is positioned to be the first...
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage Pivotal, double-blind, placebo-controlled global study will compare EG-1962 to standard of care oral nimodipine BERKELEY...
TigerText Earns Prestigious HITRUST CSF Certification 3rd-party certification from U.S. healthcare industry’s premier security testing agency confirms TigerText’s place as the most trusted name in healthcare communications SANTA MONICA, Calif. (July 27, 2016) –...
Edge Therapeutics Announces Appointment of Harry J. Sacks, M.D., FAAP, as Vice President, Clinical Development BERKELEY HEIGHTS, N.J., July 06, 2016 (GLOBE NEWSWIRE) — Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical-stage biotechnology company developing novel...
Aptuit LLC and Dimension Therapeutics Enter Strategic Partnership to Advance Select Dimension Programs Toward IND Filing GREENWICH, Connecticut and CAMBRIDGE, Massachusetts, July 7, 2016 /PRNewswire/ — Aptuit LLC, a premier global drug discovery and development...
Recent Comments